Empyrean Technology (301269.SZ) plans to invest 90 million yuan to jointly establish a fund with professional investment institutions.
Huada Jiutian (301269.SZ) announced that in order to strengthen strategic cooperative relationships with upstream and downstream enterprises in the industry and jointly cultivate the industrial ecosystem, the company has recently subscribed for shares in Qingdao Jianguangshun Chuanghui Core Equity Investment Partnership (Limited Partnership) as a limited partner, using its own funds of 90 million yuan, and has signed the Partnership Agreement for Qingdao Jianguangshun Chuanghui Core Equity Investment Partnership (Limited Partnership).
Empyrean Technology (301269.SZ) announced that in order to strengthen its strategic cooperation with upstream and downstream enterprises in the industry chain and jointly cultivate the industrial ecosystem, the company recently subscribed to shares of Qingdao Jianguangshun Chuanghuixin Equity Investment Partnership (Limited Partnership) as a limited partner with its own funds of 90 million yuan, and signed the "Partnership Agreement of Qingdao Jianguangshun Chuanghuixin Equity Investment Partnership (Limited Partnership)."
The establishment of an investment fund together with professional investment institutions is conducive to enhancing the strategic cooperation with upstream and downstream enterprises in the industry chain, promoting mutual development, continuously refining existing tools and developing new tools, and jointly building a domestic EDA ecosystem, which aligns with the companys development strategy.
Related Articles
HK Stock Market Move | INGDAN (00400.HK) surged more than 7% during trading, with mid-term revenue increasing by 98.4% and AI Token factory orders being realized.
HK Stock Market Move | JS GLOBAL LIFE (01691) rose over 6%, achieving a turnaround to profitability in the first half of the year, with the Ninja brand performing impressively.
HK Stock Market Move | TENNOR THERAP-B (06872) surged over 15% in morning trading. Positive proof-of-concept data from its Phase IIa trial of rifapentine. Phase IIb clinical trial approved and set to commence.
HK Stock Market Move | INGDAN (00400.HK) surged more than 7% during trading, with mid-term revenue increasing by 98.4% and AI Token factory orders being realized.
HK Stock Market Move | JS GLOBAL LIFE (01691) rose over 6%, achieving a turnaround to profitability in the first half of the year, with the Ninja brand performing impressively.
HK Stock Market Move | TENNOR THERAP-B (06872) surged over 15% in morning trading. Positive proof-of-concept data from its Phase IIa trial of rifapentine. Phase IIb clinical trial approved and set to commence.
RECOMMEND
